Nebula Research & Development’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.98M Buy
36,071
+18,171
+102% +$999K 0.17% 193
2025
Q1
$1.27M Sell
17,900
-25,285
-59% -$1.79M 0.12% 288
2024
Q4
$2.84M Sell
43,185
-9,514
-18% -$625K 0.33% 54
2024
Q3
$3.7M Buy
+52,699
New +$3.7M 0.44% 14
2024
Q2
Sell
-5,114
Closed -$447K 813
2024
Q1
$447K Buy
+5,114
New +$447K 0.1% 397